• Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Consensus Rating of "Moderate Buy" from Analysts

    Source: Buzz FX / 01 Jan 2025 01:41:13   America/Chicago


    Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeat January 1, 2025 Share Link copied to clipboard. Sarepta Therapeutics, Inc. ( NASDAQ:SRPT - Get Free Report ) has been g
    Read more...
Share on,